Objective To characterize the prevalence of exchange transfusion (ET), clinical
characteristics of infants receiving ET, and ET-associated morbidity and mortality. Study …

Objective To understand the risk factors associated with adverse events during exchange
transfusion (ET) in severe neonatal hyperbilirubinemia. Study design We conducted a …

The immature hepatic metabolism of bilirubin at birth is responsible for neonatal
hyperbilirubinemia, present in more than 60% of otherwise healthy infants. Icterus (or …

Introduction Exchange transfusion (ECT) is one of effective treatments for rapid reduction of
the bilirubin serum levels. The main purpose of this study was to offer greater insights into …

Background Exchange transfusion in newborns is recommended as emergency
management of hyperbilirubinemia to prevent bilirubin encephalopathy and kernicterus. Aim …

ABO incompatibility between O blood group mother and non–O blood group neonate is
common. It rarely causes anemia and hyperbilirubinemia in neonate, requiring invasive …

Objectives: The present study assessed the frequency of causes of indirect
hyperbilirubinemia (IH) requiring exchange transfusion and its immediate adverse events of …

TASK 1: Bilirubin-induced neonatal neurotoxicity Unconjugated bilirubin is a metabolite of
heme catabolism, and it exhibits Janus face for owning neurotoxicity and neuroprotective …

The chapter will describe a clinical case where exchange transfusion is indicated for severe
hyperbilirubinemia. The chapter will discuss the indications and risks-benefits of exchange …

Introduction: Exchange transfusion (ET) is the first successful treatment introduced for severe
neonatal jaundice considered to be a safe procedure but not risk free. Present study aimed …